Saili Healthcare (603716.SH): Net profit of 3.156,800 yuan in the first quarter

On April 27, Ge Longhui Medical (603716.SH) released its report for the first quarter of 2024, achieving operating income of 485 million yuan, an increase of 9.24% over the previous year; net profit attributable to shareholders of listed companies was 3.156,800 yuan, net profit attributable to shareholders of listed companies was 9097 million yuan after deducting non-recurring profit and loss, with basic earnings of 0.02 yuan per share.

Gelonghui FinanceApr 26 22:21 ET

Saili Healthcare (603716.SH) announced first-quarter results, net profit of 3.156,800 yuan

According to the Zhitong Finance App, Saili Healthcare (603716.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 485 million yuan, an increase of 9.24% over the previous year; net profit attributable to shareholders of listed companies was 3.156,800 yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 9097 million yuan; and basic earnings per share were 0.02 yuan.

Zhitong FinanceApr 26 13:01 ET

Saili Healthcare (603716.SH): Shares were not repurchased in March

Gelonghui, April 1, 丨 Saili Healthcare (603716.SH) announced that in March 2024, the company did not buy back shares through centralized bidding transactions through the Shanghai Stock Exchange trading system. As of March 31, 2024, the company has repurchased 2,070,000 shares through centralized bidding transactions through the Shanghai Stock Exchange trading system. The repurchased shares account for 1.0282% of the company's total share capital. The highest transaction price of the repurchased shares is 6.59 yuan/share, the lowest transaction price is 5.37 yuan/share, and the total amount paid is RMB 12,976,843 (excluding transaction)

Gelonghui FinanceApr 1 06:07 ET

Saili Healthcare (603716.SH): cumulative repurchase of 1.0282% of the company's shares

Gelonghui, March 4, 丨 Saili Healthcare (603716.SH) announced that as of February 29, 2024, the company had repurchased 2,070,000 shares of the company's shares through centralized bidding transactions. The repurchased shares accounted for 1.0282% of the company's total share capital. The highest transaction price for the repurchase was 6.59 yuan/share, the minimum transaction price was 5.37 yuan/share, and the total amount paid was RMB 12,976,843 (excluding transaction fees).

Gelonghui FinanceMar 4 06:07 ET

Saili Healthcare (603716.SH): Cumulative repurchase of 1.0282% of shares as of February 8

Gelonghui, Feb. 8, 丨 Saili Healthcare (603716.SH) announced that as of February 8, 2024, the company had repurchased 2.07 million shares of the company through centralized bidding transactions. The repurchased shares accounted for 1.0282% of the company's total share capital, an increase of 0.2633% compared with the previous disclosure. The highest transaction price for the newly purchased shares was 5.79 yuan/share, and the minimum transaction price was 5.37 yuan/share. The total amount paid was RMB 129.768 million (excluding transaction fees).

Gelonghui FinanceFeb 8 03:43 ET

Saili Healthcare (603716.SH): 1.54 million shares repurchased for the first time

On February 6, 2024, Gelonghui Healthcare (603716.SH) announced that on February 6, 2024, the company repurchased 1.54 million shares for the first time through the Shanghai Stock Exchange trading system, accounting for 0.7649% of the company's total share capital. The highest price of the repurchase transaction was 6.59 yuan/share, the lowest price was 6.42 yuan/share, and the total capital paid was RMB 9,930,453 (excluding transaction fees).

Gelonghui FinanceFeb 6 09:07 ET